The strong lipophilic nature of vitamin E has been exploited to design α-tocopherol-bound modified siRNAs (Toc-siRNAs), harnessing its physiological pathways, such as incorporation into lipoprotein, for the targeted delivery to apolipoprotein B (apoB) in liver cancer [41]. The gene discussed is APOB; the disease is liver cancer.